Similar articles

• Keeping prescription drugs safe and effective.

  Bryan PA. Bryan PA. Am Fam Physician. 1974 Nov;10(5):189-93. Am Fam Physician. 1974. PMID: 4421343 No abstract available.
• Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.

  Dorfman HL, Quinn VM, Brophy EA. Dorfman HL, et al. Food Drug Law J. 2006;61(4):585-622. Food Drug Law J. 2006. PMID: 17180765 No abstract available.
• The case for preemption of prescription drug failure-to-warn claims.

  Kim CH. Kim CH. Food Drug Law J. 2007;62(2):399-422. Food Drug Law J. 2007. PMID: 17632969 No abstract available.
• Toxicity of polyacrylamide and acrylamide monomer.

  King DJ, Noss RR. King DJ, et al. Rev Environ Health. 1989 Jan-Dec;8(1-4):3-16. doi: 10.1515/reveh-1989-1-403. Rev Environ Health. 1989. PMID: 2485925 Review.
• Development of new drugs in man: a review.

  Davies IB, Grind IM, Pottage A, Turner P. Davies IB, et al. J R Soc Med. 1986 Feb;79(2):96-9. doi: 10.1177/014107688607900210. J R Soc Med. 1986. PMID: 3512825 Free PMC article. Review. No abstract available.